Prognostic Value of the Multicomponent Improvement (MCI) Endpoint in Patients With Pulmonary Arterial Hypertension (PAH) Treated With Sotatercept

A.B. Waxman,D.B. Badesch, J.S.R. Gibbs, H.A. Ghofrani, M. Gomberg-Maitland, M.J.C. Humbert, V.V. Mclaughlin, I.R. Preston, R. Souza, E. Grünig, G. Kope&#;#;, G.M. Bohns Meyer, K.M. Olsson, S. Rosenkranz,Y. Zhao, A. Lau, A.G. Cornell, J. Pena, M.M. Hoeper

A14. BUILDING LEGO(LAND): LESSONS LEARNED FROM LARGE SCALE CLINICAL TRIALS IN PAH（2024）

引用 0|浏览2